continued from part 1 - Controller General of Patents, Designs, and ...

(12) PATENT APPLICATION PUBLICATION (21) Application No.6298/DELNP/2008 A
(19) INDIA
(22) Date of filing of Application :18/07/2008 (43) Publication Date : 24/10/2008
(54) Title of the invention : CHEMICAL COMPOUNS
(51) International classification :C07D 205/04 (71)Name of Applicant :
(31) Priority Document No :06300120.0
1)ASTRAZENECA AB
(32) Priority Date :09/02/2006
Address of Applicant :SE-151 85 SODERTALJE, SWEDEN
(33) Name of priority country :EPO
Sweden
(86) International Application No :PCT/GB2007/000404 (72)Name of Inventor :
Filing Date
:07/02/2007
1)ARNOULD JEAN-CLAUDE
(87) International Publication No :WO 2007/091046 2)DELOUVRIE BENEDICTE
(61) Patent of Addition to Application
Number
Filing Date
:NA
:NA
3)KETTLE JASON, GRANT
(62) Divisional to Application Number :NA
Filing Date
:NA
(57) Abstract :
The present invention relates to compounds that inhibit a5bI function, processes for their preparation, pharmaceutical compositions
containing them as the active ingredient, to their use as medicaments and to their use in the manufacture of medicaments for use in the
treatment in warm blooded animals such as humans ofdiseases that have a significant angiogenesis of vascular component such as for
treatment of solid tumours. The present invention also relates to compounds that inhibit a5bl, and also that exhibit appropriate
selectivity profilc(s) against other integrins.
No. of Pages : 129 No. of Claims : 16
The Patent Office Journal 24/10/2008 25807